Page last updated: 2024-10-28

ibuprofen and Parkinsonian Disorders

ibuprofen has been researched along with Parkinsonian Disorders in 7 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research Excerpts

ExcerptRelevanceReference
"Standard methods were used to confirm Parkinsonism/neuroprotection."1.48Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density. ( Bala, L; Patel, DK; Singh, A; Singh, MP; Tripathi, P, 2018)
"Treatment with ibuprofen or piroxicam in combination with l-dopa preserved the effect of l-dopa at the end of week 10, delayed the development of dyskinesia and decreased striatal COX-2 and VEGF levels."1.43Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis. ( Moustafa, YM; Teema, AM; Zaitone, SA, 2016)
"Post treatment with ibuprofen blocked the depletion of glutathione induced by rotenone and increased the basal levels of this antioxidant in the striatum."1.40Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease. ( Baggio, CH; Barbiero, JK; Bassani, TB; Gradowski, RW; Maria-Ferreira, D; Santiago, RM; Vital, MA; Zaminelli, T, 2014)
"Ibuprofen was shown to protect neurons against MPTP-induced injury in the striatum."1.39Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease. ( Członkowski, A; Joniec, I; Kurkowska-Jastrzębska, I; Swiątkiewicz, M; Zaremba, M, 2013)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Singh, A2
Tripathi, P2
Singh, S1
Bala, L1
Patel, DK1
Singh, MP1
Corwin, C1
Nikolopoulou, A1
Pan, AL1
Nunez-Santos, M1
Vallabhajosula, S1
Serrano, P1
Babich, J1
Figueiredo-Pereira, ME1
Swiątkiewicz, M1
Zaremba, M1
Joniec, I1
Członkowski, A2
Kurkowska-Jastrzębska, I2
Zaminelli, T1
Gradowski, RW1
Bassani, TB1
Barbiero, JK1
Santiago, RM1
Maria-Ferreira, D1
Baggio, CH1
Vital, MA1
Teema, AM1
Zaitone, SA1
Moustafa, YM1
Członkowska, A1

Reviews

1 review available for ibuprofen and Parkinsonian Disorders

ArticleYear
Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.
    Inflammopharmacology, 2021, Volume: 29, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Humans; Ibuprofen; Inflammation; Neu

2021

Other Studies

6 other studies available for ibuprofen and Parkinsonian Disorders

ArticleYear
Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density.
    Molecular neurobiology, 2018, Volume: 55, Issue:3

    Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Dendrites; Dend

2018
Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
    Journal of neuroinflammation, 2018, Sep-20, Volume: 15, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Disease Models, Animal; Enc

2018
Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:5

    Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Basal Ganglia; Cytoprotection; Di

2013
Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease.
    Neurotoxicity research, 2014, Volume: 26, Issue:4

    Topics: Animals; Antidepressive Agents; Antioxidants; Brain; Catalase; Depression; Dose-Response Relationshi

2014
Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis.
    Neuropharmacology, 2016, Volume: 107

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dyskinesia, Drug-Induced; Female; Ibuprofen; Levod

2016
Ibuprofen and the mouse model of Parkinson's disease.
    Annals of neurology, 2006, Volume: 59, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Ibuprofen; Mice; Ne

2006